首页> 外国专利> METHOD CORRECTION endothelial dysfunction SOLUTION homeopathic dilutions of antibodies to endothelial nitric oxide synthase RIGHTS IN COMPLEX WITH SOLUTIONS homeopathic dilutions of antibodies to the C-terminal fragment of angiotensin II receptor

METHOD CORRECTION endothelial dysfunction SOLUTION homeopathic dilutions of antibodies to endothelial nitric oxide synthase RIGHTS IN COMPLEX WITH SOLUTIONS homeopathic dilutions of antibodies to the C-terminal fragment of angiotensin II receptor

机译:方法纠正内皮功能障碍解决方案血管内皮一氧化氮合酶抗体的顺势疗法稀释液与溶液的复杂性血管紧张素II受体C端抗体的抗体顺势疗法稀释液

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to experimental cardiology, and concerns the L-NAME-induced endothelial dysfunction correction. That is ensured by introducing the mixture of solutions of homoeopathic dilutions of rabbit monoclonal antibodies to human endothelial nitrogen oxide synthase C12, C30, C200 (9 ml/kg/day) in complex with the mixture of solutions of homoeopathic dilutions of angiotensin II receptor C-terminal fragment antibodies C12, C30, C200 in a dose of 9 ml/kg/day.;EFFECT: method provides the effective endothelial dysfunction correction in the specific experimental environment.;1 tbl
机译:技术领域本发明涉及医学,即涉及实验性心脏病学,并且涉及L-NAME诱导的内皮功能障碍的校正。通过将与人血管内皮氮氧化物合酶C12,C30,C200(9 ml / kg /天)的兔单克隆抗体的同种异体稀释液的混合物与血管紧张素II受体C的同种异体稀释液的混合物混合引入混合物中来确保-末端片段抗体C12,C30,C200,剂量为9 ml / kg /天。效果:该方法可在特定的实验环境中提供有效的内皮功能障碍校正。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号